Our team understands how important purity is when conducting sensitive laboratory research and analysis
On April 15, the FDA published a notice scheduling a meeting of the Pharmacy Compounding Advisory Committee (PCAC) for July 2324, 2026, at which the committee will consider whether to recommend certain peptide bulk drug substances for inclusion on the 503A bulks list
Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
It also lists medullary thyroid carcinoma history, multiple endocrine neoplasia type 2, severe kidney disease, and acute pancreatitis as reasons to avoid these agents
Chair of RACGP Specific Interests Obesity Management, GP and dietitian, Dr Terri-Lynne South, agrees that the study shows a potential reduction in reliability of oral contraceptives due to the delay in gastric emptying caused by the medications, but stressed the word potential